NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+8.83%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$824M
AUM Growth
-$219M
(-21%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-27.02%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
132
New
16
Increased
19
Reduced
47
Closed
17
Top Buys
| 1 |
The Bancorp
TBBK
|
$13.3M |
| 2 |
Lyra Therapeutics
LYRA
|
$7.14M |
| 3 |
Amneal Pharmaceuticals
AMRX
|
$5.11M |
| 4 |
Cytokinetics
CYTK
|
$4.87M |
| 5 |
InspireMD
NSPR
|
$4.67M |
Top Sells
| 1 |
TA
TravelCenters of America LLC
TA
|
$51.7M |
| 2 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$45.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$25.2M |
| 4 |
Travel + Leisure Co
TNL
|
$24.4M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$13.7M |
Sector Composition
| 1 | Healthcare | 51.51% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Communication Services | 8.45% |
| 5 | Industrials | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MillerKnoll
MLKN
$1.47B
| $8.98M | 0.87% |
607,883
-326,150
| -35% | -$4.82M |
|
27
DXP Enterprises
DXPE
$1.95B
| $7.78M | 0.75% |
213,672
-124,418
| -37% | -$4.53M |
|
|
ILPT
28
Industrial Logistics Properties Trust
ILPT
$407M
| $7.78M | 0.75% |
2,357,284
+1,097,000
| +87% | +$3.62M |
|
29
Payoneer
PAYO
$2.4B
| $7.76M | 0.75% |
1,612,862
+102,247
| +7% | +$492K |
|
30
Reading International Class A
RDI
$33.8M
| $7.65M | 0.74% |
2,885,514
-10,181
| -0.4% | -$27K |
|
31
Alta Equipment Group
ALTG
$275M
| $7.33M | 0.71% |
422,812
-204,295
| -33% | -$3.54M |
|
|
32
Syndax Pharmaceuticals
SNDX
$1.47B
| $6.76M | 0.65% |
323,134
-652,571
| -67% | -$13.7M |
|
33
Dyne Therapeutics
DYN
$2.02B
| $6.67M | 0.65% |
593,164
+414,263
| +232% | +$4.66M |
|
|
34
Amneal Pharmaceuticals
AMRX
$3.02B
| $6.66M | 0.64% |
2,149,305
+1,649,305
| +330% | +$5.11M |
|
35
eHealth
EHTH
$125M
| $6.43M | 0.62% |
800,000
+400,000
| +100% | +$3.22M |
|
36
Ventyx Biosciences
VTYX
$180M
| $6.32M | 0.61% |
192,671
| – | – |
|
|
CBAY
37
DELISTED
Cymabay Therapeutics
CBAY
| $6.06M | 0.59% |
553,307
-1,236,796
| -69% | -$13.5M |
|
|
38
Cytokinetics
CYTK
$6.34B
| $5.85M | 0.57% |
179,257
+149,257
| +498% | +$4.87M |
|
39
Abeona Therapeutics
ABEO
$353M
| $5.65M | 0.55% |
1,401,880
-26,795
| -2% | -$108K |
|
|
PNT
40
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $5.18M | 0.5% |
572,191
| – | – |
|
|
41
InspireMD
NSPR
$101M
| $4.67M | 0.45% |
+1,860,405
| New | +$4.67M |
|
42
Cidara Therapeutics
CDTX
$1.6B
| $4.48M | 0.43% |
198,095
-38,387
| -16% | -$868K |
|
43
Tourmaline Bio
TRML
$687M
| $4.41M | 0.43% |
+145,003
| New | +$4.41M |
|
44
Strata Skin Sciences
SSKN
$7.42M
| $4.17M | 0.4% |
439,369
| – | – |
|
45
Dianthus Therapeutics
DNTH
$853M
| $3.79M | 0.37% |
+312,500
| New | +$3.79M |
|
46
TELA Bio
TELA
$63M
| $3.61M | 0.35% |
356,092
+100,000
| +39% | +$1.01M |
|
47
Amylyx Pharmaceuticals
AMLX
$910M
| $3.55M | 0.34% |
+164,500
| New | +$3.55M |
|
48
Fortress Biotech
FBIO
$110M
| $3.51M | 0.34% |
426,047
-35,145
| -8% | -$290K |
|
49
United Therapeutics
UTHR
$18.1B
| $3.47M | 0.34% |
15,700
| – | – |
|
50
IDEAYA Biosciences
IDYA
$2.38B
| $3.43M | 0.33% |
145,860
-107,620
| -42% | -$2.53M |
|